In:
Journal of Child Neurology, SAGE Publications, Vol. 24, No. 1 ( 2009-01), p. 5-8
Kurzfassung:
Schwartz-Jampel syndrome is a rare autosomal recessive disorder characterized by myotonia and skeletal dysplasia. Botulinum toxin A is emerging as a therapeutic option for patients with this syndrome. This study describes the use of botulinum toxin A in 4 children with Schwartz-Jampel syndrome. The response to this therapeutic modality was limited and variable.
Materialart:
Online-Ressource
ISSN:
0883-0738
,
1708-8283
DOI:
10.1177/0883073808320621
Sprache:
Englisch
Verlag:
SAGE Publications
Publikationsdatum:
2009
ZDB Id:
2068710-2